Publications by authors named "Clive Zent"

Claim this Profile
E
Expert consensus opinion on the management of hairy cell leukemia in elderly patients.
Tamar Tadmor, Judit Demeter, Andrei Fagarasanu, Robert J Kreitman, Sameer A Parikh, Clive S Zent

Leuk Lymphoma· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real World Data Identifies Care Needs in Adolescent and Young Adult Patients with Lymphoma: A Matched Cohort Study.
John Mariano, Myla Strawderman, Eric Snyder, Tina Faugh, Danielle S Wallace, Clive S Zent

J Adolesc Young Adult Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.
Jennifer E Bruno, Christine A Herne, Andrea M Baran, Karl R VanDerMeid, Paul M Barr, Clive S Zent

Am J Hematol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukemia variant and WHO classification correspondence Re: 5 edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji, Clive S Zent

Leukemia· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.
Brian T Hill, Shuo Ma, Clive S Zent, Andrea M Baran, Danielle S Wallace

Blood Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.
Michael T Brady, Nathan Laniewski, Myla Strawderman, Charles C Chu, Preshetha Kanagaiah, Clive S Zent

Am J Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-mediated phagocytosis in cancer immunotherapy.
Carly M Van Wagoner, Fátima Rivera-Escalera, Nydia C Jaimes-Delgadillo, Charles C Chu, Clive S Zent

Immunol Rev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of New-Onset Atrial Fibrillation Associated With Targeted Treatment of Lymphoma.
Amole Ojo, Ilan Goldenberg, Scott McNitt, Susan Schleede, Carla Casulo, Clive S Zent

JACC Adv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population.
Kriti Thapa, Myla Strawderman, Patrick M Reagan, Paul M Barr, Clive S Zent

Clin Lymphoma Myeloma Leuk· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia.
Danielle S Wallace, Clive S Zent, Andrea M Baran, Patrick M Reagan, Carla Casulo

Blood Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions.
Jeremiah E Moore, Paige C Bloom, Charles C Chu, Jennifer E Bruno, Christine A Herne, Clive S Zent

Leuk Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of sex on outcomes in patients with hairy cell leukemia. An HCL patient data registry analysis.
Narendranath Epperla, Qiuhong Zhao, Mirela Anghelina, Jasmine Neal, James S Blachly, Clive S Zent

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of splenectomy in management of splenic B-cell lymphomas.
William J Archibald, Andrea M Baran, AnnaLynn M Williams, Rabih M Salloum, W Richard Burack, Clive S Zent

Leuk Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders.
Saadia Sherazi, Susan Schleede, Scott McNitt, Carla Casulo, Jeremiah E Moore, Clive S Zent

J Am Heart Assoc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a distributed international patient data registry for hairy cell leukemia.
Leslie A Andritsos, Mirela Anghelina, Jasmine Neal, James S Blachly, Puneet Mathur, Clive S Zent

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Farhad Ravandi, Robert J Kreitman, Enrico Tiacci, Leslie Andritsos, Versha Banerji, Clive S Zent

Blood Cancer J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemia" [Leuk. Res. 120 (2022) 106919].
Mirela Anghelina, Michelle J Naughton, Qiuhong Zhao, Amy S Ruppert, Jasmine Neal, Clive S Zent

Leuk Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-driven research: Initial results from a prospective health-related quality of life study performed at the request of patients living with hairy cell leukemia.
Mirela Anghelina, Michelle J Naughton, Qiuhong Zhao, Amy S Ruppert, Jasmine Neal, Clive S Zent

Leuk Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact.
Jonathan J Pinney, Sara K Blick-Nitko, Andrea M Baran, Derick R Peterson, Hannah E Whitehead, Clive S Zent

Haematologica· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent polyclonal B-cell lymphocytosis: Illustration of the great mimicker of low-grade B-cell lymphoma.
Dingani Nkosi, Clive S Zent, Siba El Hussein

EJHaem· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib Restores Tumor-specific Adaptive Immunity in Chronic Lymphocytic Leukemia.
Clive S Zent

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.
Michael Grever, Leslie Andritsos, Versha Banerji, Jacqueline C Barrientos, Seema Bhat, Clive Zent

Leukemia· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapy for treatment of patients with classical hairy cell leukemia.
Jeremiah E Moore, Kendra Delibert, Andrea M Baran, Andrew G Evans, Jane L Liesveld, Clive S Zent

Leuk Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing of the guard: Leukemia Research 2021.
Clive S Zent, David M Ross

Leuk Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Activation in the Treatment of B-Cell Malignancies.
Clive S Zent, Jonathan J Pinney, Charles C Chu, Michael R Elliott

Antibodies (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis